Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
7.77
+0.09 (1.17%)
Aug 18, 2026, 2:01 PM EDT - Market open
CPIX Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -10.92 | -2.84 | -6.48 | -6.28 | -5.57 | -3.51 |
Depreciation & Amortization | 5.28 | 5.29 | 6.04 | 5.77 | 5.33 | 4.61 |
Asset Writedown & Restructuring Costs | - | - | - | 3.34 | - | - |
Loss (Gain) From Sale of Investments | 0.01 | 0.01 | - | - | - | - |
Stock-Based Compensation | 0.44 | 0.41 | 0.3 | 0.37 | 0.45 | 0.74 |
Other Operating Activities | -0.22 | -0.1 | -1.77 | -1.74 | -2.19 | -5.67 |
Change in Accounts Receivable | -3.1 | -5.24 | -1.94 | 3.4 | -6.12 | 5.5 |
Change in Inventory | 2.14 | 2.24 | 2.41 | -0.02 | 0.91 | 4.82 |
Change in Accounts Payable | 9.44 | 6.71 | -0.99 | 3.72 | 14.54 | -0.76 |
Change in Other Net Operating Assets | -0.94 | -1.55 | 1.82 | -2.47 | 1.11 | -1.38 |
Operating Cash Flow | 0.75 | 4.93 | -0.61 | 6.09 | 8.45 | 6.34 |
Operating Cash Flow Growth | -89.53% | - | - | -27.91% | 33.28% | 17.13% |
Capital Expenditures | -0.06 | -0.1 | -0.07 | -0.28 | -0.1 | -0.1 |
Cash Acquisitions | - | - | - | - | -13.5 | - |
Sale (Purchase) of Intangibles | -0.08 | -0.08 | -0.11 | -0.17 | -1.97 | -0.25 |
Investment in Securities | -6.23 | -4.48 | - | - | - | - |
Other Investing Activities | 0.62 | -0.05 | 0.24 | 0.35 | 1.9 | -0.15 |
Investing Cash Flow | -5.75 | -4.71 | 0.06 | -0.11 | -13.67 | -0.5 |
Long-Term Debt Issued | - | - | 38.49 | 31.48 | 52.9 | 59 |
Long-Term Debt Repaid | - | -10.04 | -36 | -34.89 | -51.7 | -59 |
Net Debt Issued (Repaid) | -5.24 | -10.04 | 2.49 | -3.42 | 1.2 | - |
Issuance of Common Stock | - | 5.27 | - | - | - | - |
Repurchase of Common Stock | -0.07 | -0.26 | -0.58 | -0.74 | -1.05 | -1.39 |
Other Financing Activities | -1.91 | -1.71 | -1.72 | -3.27 | -2.21 | -2.17 |
Financing Cash Flow | -7.22 | -6.75 | 0.2 | -7.42 | -2.06 | -3.55 |
Net Cash Flow | -12.22 | -6.52 | -0.36 | -1.44 | -7.28 | 2.29 |
Free Cash Flow | 0.68 | 4.83 | -0.68 | 5.81 | 8.35 | 6.24 |
Free Cash Flow Growth | -90.27% | - | - | -30.40% | 33.86% | 18.29% |
Free Cash Flow Margin | 1.54% | 10.86% | -1.79% | 14.70% | 19.88% | 17.34% |
Free Cash Flow Per Share | 0.05 | 0.33 | -0.05 | 0.41 | 0.57 | 0.42 |
Levered Free Cash Flow | -0.19 | 6.44 | -0.8 | 9.33 | 2.4 | 0.36 |
Unlevered Free Cash Flow | 0.12 | 6.75 | -0.42 | 9.75 | 2.77 | 0.42 |
Cash Income Tax Paid | - | -0 | 0.02 | 0.11 | 0 | -0 |
Change in Working Capital | 7.54 | 2.16 | 1.29 | 4.63 | 10.44 | 8.18 |